PATENT CLAIM ANALYSIS

Application Number: 16140750
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["435", "006000"]

Abstract:
Disclosed are compounds of Formula (I) wherein: the two dotted lines represent either two single or two double bonds; Q is: R 1  is F, Cl, —CN, or —CH 3 ; R 2  is Cl or —CH 3 ; R 3  is —C(CH 3 ) 2 OH or —CH 2 CH 2 OH; R a  is H or —CH 3 ; each R b  is independently F, Cl, —CH 3 , and/or —OCH 3 ; and n is zero, 1, or 2. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Claim (Index 3):
The compound according to  claim 2  wherein: R 1  is F or Cl.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 2.05263
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15809437', '14314602', '15625417', '14392355', '15521194']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6925241005325723
- 35 USC 102 Novelty (BERT): 0.6321063918619941
- Combined Prediction Score: 0.6864823296655145
- Mean Citation Score: 520.047912
- Max Citation Score: 583.20874
- Similarity Product: 555.7282020325625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test